Juul to cut 30% of its workforce in bid to cut costs and boost profitability

Juul to cut 30% of its workforce in bid to cut costs and boost profitability


Juul Labs signage is seen in the window of a store in San Francisco, June 25, 2019.

David Paul Morris | Bloomberg | Getty Images

Juul Labs said Wednesday it’s planning to cut about 30% of its workforce as it looks to cut costs and boost profits.

The layoffs will affect roughly 250 people, reducing the company’s headcount to about 650, a company spokesperson said.

This will reduce operating expenses by $225 million, the Juul spokesperson added.

Juul – which is seeking federal authorization to keep its e-cigarette products on the market – said the cuts will improve its margins and free up cash for litigation settlements.

“Today, Juul Labs is announcing a company restructuring aimed at reducing our operating costs and positioning us to continue to advance our mission during a period of regulatory and marketplace uncertainty,” the company said in a news release.

Last year, the vaping giant had its products ordered off the market by the Food and Drug Administration. Juul appealed the decision and the ban was reversed for the time being.

The company later secured enough financing from early investors to avoid bankruptcy. It also announced plans at the time to lay off nearly a third of staff.

Since then, Juul has been trying to raise more capital from investors as it awaits a decision from U.S. regulators on whether its current products can remain on the market, a company spokesperson said.

The company’s also been embroiled in costly legal battles, paying over $1 billion worth of settlements to 45 states for its role in sparking a national surge in teen vaping.

Earlier this week, Juul was sued by Marlboro maker Altria Group, which previously held significant stake in Juul, for alleged patent infringement over certain e-vapor products owned by subsidiary NJOY.

In response to the suit, a Juul spokesperson told CNBC, “We stand behind our intellectual property and will continue to pursue our infringement claims.”



Source

Healthy Returns: New study casts doubts on RFK Jr.’s reasons for gutting key vaccine panel
Health

Healthy Returns: New study casts doubts on RFK Jr.’s reasons for gutting key vaccine panel

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. speaks as he attends a press conference with Centers for Medicare and Medicaid Services Administrator Mehmet Oz to discuss health insurance reform, at the Department of Health and Human Services in Washington, D.C., U.S., June 23, 2025. Kevin Mohatt | Reuters A version of […]

Read More
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Health

Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data

Shares of Viking Therapeutics fell more than 30% in premarket trading Tuesday after the company released mid-stage trial data on its obesity pill that disappointed investors.  The results could be a blow to Viking, which was once seen as a hot M&A target as pharmaceutical companies scramble to join the booming market for obesity and […]

Read More
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Health

Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price, as drugmakers face mounting political pressure to lower prices in […]

Read More